Skip to content

Predictive Risk Factors for Pancreatic Fistula Grade C After Pancreaticoduodenectomy

Predictive Risk Factors for Pancreatic Fistula Grade C After Pancreaticoduodenectomy: Prospective Large Observational Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02322424
Enrollment
3000
Registered
2014-12-23
Start date
2014-12-31
Completion date
2017-06-30
Last updated
2014-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease of Pancreatic Head or Periampullary Lesions to Require Pancreaticoduodenectomy

Brief summary

Pancreatic fistula (PF) grade C, defined by the International Study Group of Pancreatic Fistula (ISGPF) is associated with a life-threatening complication after pancreaticoduodenectomy(PD). Therefore, The aim of this study is to clarify the risk factors for grade C PF by Japan and Taiwan cooperative project.

Detailed description

Pancreatic fistula (PF) grade C, defined by the International Study Group of Pancreatic Fistula (ISGPF) is associated with a life-threatening complication after pancreaticoduodenectomy(PD). The rate of grade C PF has been reported 2.5-6%, however, it is critical complication after PD. A large number of enrolled patients will be needed to clarify the risk factors for grade C PF. Therefore, this study design is prospective large observational study at multi-center in Japan and Taiwan.

Interventions

PROCEDUREpancreaticoduodenectomy

Sponsors

Wakayama Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Disease of pancreatic head or periampullary lesions to require pancreaticoduodenectomy 2. Age: 20 years or older 3. PS (ECOG performance status scale) 0-1 at the time of enrollment 4. Ability to understand and the willingness to sign a written informed consent document

Exclusion criteria

1. patients with severe respiratory disorder required oxygen inhalation 2. patients with severe liver dysfunction 3. patients with chronic renal failure with dialysis 4. patients who are unfit for this study as determined by the attending physician

Design outcomes

Primary

MeasureTime frame
Incidence of pancreatic fistula grade C90 days after pancreaticoduodenectomy

Secondary

MeasureTime frame
Incidence of clinical relevant pancreatic fistula (grade B and grade C)90 days after pancreaticoduodenectomy
Incidence of postpancreatecomy hemorrhage(PPH)90 days after pancreaticoduodenectomy
Cut-off value of drain amylase fluid on POD1 to distinguish pancreatic fistula grade C with grade A and grade B90 days after pancreaticoduodenectomy
Incidence of overall pancreatic fistula (grade A, grade B and grade C)90 days after pancreaticoduodenectomy
Morbidity90 days after pancreaticoduodenectomy
30-day mortality30 days after pancreaticoduodenectomy
90-day mortality90 days after pancreaticoduodenectomy
Cut-off value of drain amylase fluid on POD1 to distinguish pancreatic fistula grade B and C with grade A90 days after pancreaticoduodenectomy

Countries

Taiwan

Contacts

Primary ContactHiroki Yamaue, M.D., PhD.
yamaue-h@wakayama-med.ac.jp+81-73-441-0613
Backup ContactHiroki Yamaue, M.D., PhD.
trial-jt@wakayama-med.ac.jp+81-73-441-0613

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026